Roche to Invest $7.1 Billion in Game-Changing Inflammatory Disease Treatment
Updated posts 2026 Swiss healthcare leader, Roche, is making waves with a $7.1 billion deal to acquire Telavant Holdings, a ...
© 2026 ImpactWealth | Disclaimer – Privacy Policy